Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 97,290 $ 179,512
Prepaid expenses 255,960 0
Total Current Assets 353,250 179,512
Deferred Offering Costs 0 215,448
Cash and securities held in Trust Account 316,264,504 0
Total Assets 316,617,754 394,960
Current liabilities    
Accrued expenses 374,902 2,286
Accrued offering costs 15,450 94,960
Promissory note – related party 0 275,000
Total Current Liabilities 390,352 372,246
Warrant liabilities 10,216,242 0
Total Liabilities 10,606,594 372,246
Commitments (Note 7)
Class A common stock subject to possible redemption, 31,625,000 and no shares at redemption value as of September 30, 2021 and December 31, 2020, respectively 316,250,000 0
Stockholders' Equity (Deficit)    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued and outstanding
Additional paid-in capital 0 24,209
Accumulated deficit (10,239,714) (2,286)
Total Stockholders' Equity (Deficit) (10,238,840) 22,714
Total Liabilities and Stockholders' Equity (Deficit) 316,617,754 394,960
Common Class A [Member]    
Current liabilities    
Class A common stock subject to possible redemption, 31,625,000 and no shares at redemption value as of September 30, 2021 and December 31, 2020, respectively   316,250,000
Stockholders' Equity (Deficit)    
Common stock 83 0
Common Class B [Member]    
Stockholders' Equity (Deficit)    
Common stock 791 791
Total Stockholders' Equity (Deficit) $ 791 $ 791